Government Affairs
Refine Search
Biotechnology
China will complete draft development plans for several strategic emerging industries by the end of September, said a person involved with the drafting of the plans reported by the China's 21st Century Business Herald. 12 August 2010
Pharmaceutical
The macro-environment for the Greek pharmaceutical industry remains challenging according to a new report from Espicom Business Intelligence. In addition to the huge budget deficit, recession in Greece is still ongoing with Gross Domestic Product projected to contract further in 2010 and 2011, after a contraction of 2.0% in 2009. 11 August 2010
Pharmaceutical
Ahead of the federal elections due to take place in Australia on .August 21, the research-based drug trade group Medicines Australia and the Australian Medical Association have set out their wish lists for government action, whoever wins. 11 August 2010
Pharmaceutical
As part of its ongoing advocacy efforts to spur US President Barack Obama and the Administration to do more on AIDS, the AIDS Healthcare Foundation (AHF) is rolling out an ad headlined 'President Obama, The War on AIDS Has Not Been Won,' which compares the amount of US dollars spent fighting the global AIDS epidemic versus that on the war in Afghanistan. 11 August 2010
Generics
India's Parliamentary Standing Committee on Health and Family Welfare has proposed a series of measures to make drugs more affordable and accessible to ordinary people, such as increasing the number of drugs under price control, a blanket cap on profit margins of all medicines and promoting the use of generic drugs, reports the Times of India, which notes that the measures, which seek to tackle the problem of the rising price of drugs, that now account for up to 80% of total health care costs, 'are bound to raise the hackles of the pharmaceutical industry.' 10 August 2010
Pharmaceutical
Islamic countries have acknowledged the importance of self-reliance in vaccine production and are committed to establishing closer cooperation towards achieving this end, as they ended their 6th Annual Meeting of Self-Reliance in Vaccine Production (SRVP), in Bandung, Indonesia. 9 August 2010
article
Some pharmaceutical companies have been exploiting a 'loophole' in the German government's widely trumpeted clampdown on drug prices (The Pharma Letter, July 9). The legislation will now have to be tightened, which the Ministry of Health says will happen by January 1 next year. What an 'embarrassing lapse' for Health Minister Philipp Roesler, writes Jennifer Lachman in the FT Deutschland. 6 August 2010
Pharmaceutical
US President Barack Obama's national health care mandate will undoubtedly lead to the largest expansion of government in the history of the USA and will cost taxpayers at least $1,000 billion over 10 years. 'And that's just the beginning, says Sally Pipes, author of The Truth About Obamacare, in a posting on the web site of the think tank Pacific Research Institute. 6 August 2010
Pharmaceutical
Michael Bennet, Democrat Senator for the US state of Colorado, is making a push to protect consumers by improving the safety and quality of US drugs. 5 August 2010
Pharmaceutical
The USA's Centers for Medicare and Medicaid Services (CMS) yesterday issued the agreement that drug manufacturers will use to provide savings of about 50% on brand name drugs and biologics for people with Medicare Part D who hit the Part D drug benefit coverage gap, or 'donut hole,' in 2011. 3 August 2010
Generics
The US Senate Appropriations Committee last week voted to pass Wisconsin Democrat Senator Herb Kohl's bill intended to reduce the number of pay-for-delay settlements that keep generic drugs off the market. 2 August 2010
Pharmaceutical
A new report from the US free-market think tank Pacific Research Institute argues that American patients would benefit if the Food and Drug Administration did not have a monopoly on regulations. 30 July 2010
Generics
Commenting on US Federal Trade Commission Chairman Jon Leibowitz' testimony before the House of Representatives Committee on the Judiciary, Subcommittee on Courts and Competition Policy (The Pharma Letter July 28), the Generic Pharmaceutical Association (GPhA) described it as misguided and failing to present the whole story regarding patent settlements. 29 July 2010
Pharmaceutical
The UK and India are planning wide-ranging agreements in science and technology to cement bilateral cooperation in medicine, R&D, ICT, energy and education to the benefit of both countries. 29 July 2010
Pharmaceutical
A comprehensive report comparing the use of medicines in the UK with that in other countries was published yesterday by the UK Department of Health, showing that Britain still lags behind comparable countries in Europe and elsewhere on its use of newer cancer treatments and medicines for chronic diseases such as rheumatoid arthritis, multiple sclerosis and dementia under the National Health Service. 28 July 2010
Generics
The US Senate has approved a $60 billion measure to fund the troop buildup in Afghanistan after refusing to include $10 billion in state aid sought by the House to prevent an estimated 140,000 teacher layoffs, and also dropped the 'Preserve Access to Affordable Generics Act,' which is intended to curb pharmaceutical patent settlement agreements - so-called 'pay-for-delay' deals between research-based pharmaceutical companies and generic drugmakers, which the House of Representatives passed earlier by a vote of 239 to 182 (The Pharma Letter July 5). 28 July 2010
Pharmaceutical
Spirited efforts in Australia to raise awareness of hepatitis C have increased the number of diagnosed cases and expanded the base of patients available for treatment, thus enabling the introduction of novel treatments in this market sector, says a new multi-client report from Frost & Sullivan. 28 July 2010
Pharmaceutical
The unwillingness of the global AIDS community to accept the status quo is fuelling a new era of scientific innovation to drive novel ways of treating and preventing HIV, organizers of the XVIII International AIDS Conference taking place in Vienna, Austria, said yesterday. 22 July 2010
Generics
The Global Fund to fight HIV/AIDS, tuberculosis and malaria and six manufacturers of quality-assured malaria drugs have finalized agreements to place affordable life-saving malaria drugs within reach of millions of people in need, especially children. 21 July 2010
Generics
Treatment activists and legal experts gathered at the XVIII International AIDS Conference in Vienna, Austria, are calling on the European Union to immediately stop its aggressive push for higher intellectual property protection and enforcement through various bilateral and multilateral forums that threaten access to safe, effective and affordable generic HIV medicines. 21 July 2010
Pharmaceutical
The nomination of Robert F Kennedy Jr — known as RFK Jr — for the role of US Secretary of the Department of Health and Human Services (HHS) President-elect Donald Trump sent shares in vaccine companies sharply downwards. 22 November 2024
article
The UK government has reappointed BioIndustry Association (BIA) chairman Daniel Mahony as its Life Sciences Investment Envoy. 21 November 2024
Pharmaceutical
The Danish government’s newly-unveiled health reform has been praised for tackling chronic disease care and health inequalities while driving health innovation. 18 November 2024
Pharmaceutical
New research published by the European Federation of Pharmaceutical Industries and Associations (EFPIA) provides in-depth analysis of the economic footprint of the pharmaceutical industry in Europe, across member states and compares Europe to other regions of the world. 18 November 2024
Pharmaceutical
Johnson & Johnson has taken legal action to defend a contentious rebate initiative, filing a lawsuit in the US District Court for the District of Columbia. 15 November 2024
Pharmaceutical
The share prices of Pfizer, GSK, Novavax and other vaccine companies were all markedly lower on Friday. This was not due to the publication of disappointing research results in the sphere, or an ominous stance taken by a major regulator on a key filing, but rather a political development that could spell trouble for the vaccines field as a whole. 15 November 2024
Biotechnology
BeiGene has announced plans to rebrand as BeOne Medicines, a move the cancer specialist says reflects its commitment to fighting cancer through collaboration. 15 November 2024
Pharmaceutical
Danish patients are being offered fewer innovative treatments than Norwegians and Swedes, a new estimate from the Danish Medicines Council shows. 11 November 2024
Pharmaceutical
According to the Swedish pharma trade group Lif, it is positive that, in the updated life science strategy, the government expresses an ambition for Sweden to become more attractive for research investments. 11 November 2024
Pharmaceutical
Li Li, Commissioner of China's National Medical Products Administration (NMPA), and Mette Aaboe Hansen, interim director general of Danish Medicines Agency, have signed a letter of intent to promote bilateral cooperation in regulation of drugs and medical devices. 11 November 2024
Pharmaceutical
Following the news that Donald Trump is the winner of the 2024 US Presidential Election, Morningstar Equity analyst Julie Utterback has published a new note about the impact of this on the managed-care industry. 7 November 2024
Pharmaceutical
UK pharma major AstraZeneca, which has invested heavily in China, hosted a sell-side analyst call on Wednesday (November 6) to discuss the recent media reports about ongoing investigations in China. 7 November 2024
Pharmaceutical
Some of the UK’s leading academics and industry professionals have welcomed Chancellor Rachel Reeves’ £520 million ($669 million) pledge to develop the country’s medicine manufacturing capabilities. 6 November 2024
Pharmaceutical
European regulators will decide by December 6 whether Novo Holdings, the controlling shareholder of Danish pharma giant Novo Nordisk, can finalize its $16.5 billion acquisition of contract drug manufacturer Catalent. 5 November 2024
Pharmaceutical
The Danish government is rolling out the red carpet and welcomes several pharmaceutical companies. 4 November 2024
Generics
Medicines for Europe has launched a study of market barriers faced by European generics and biosimilar pharmaceutical companies operating in 11 key third-country markets. 31 October 2024
Pharmaceutical
Following the first Labour budget for 14 years, the Association of the British Pharmaceutical Industry (ABPI) welcomes Chancellor Rachel Reeves’ measures to improve UK life sciences competitiveness. 30 October 2024
Pharmaceutical
HOPO Therapeutics has been awarded a contract valued at up to $226 million from the Biomedical Advanced Research and Development Authority (BARDA). 29 October 2024
Pharmaceutical
The Danish government has presented part of the plan for a future life science strategy, which has been welcomed by the industry. 28 October 2024
Biotechnology
Legend Biotech has removed Genscript Biotech as its majority shareholder, in a move coinciding with rising US concerns over Chinese ties within the biotech sector. 24 October 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze